Literature DB >> 17760457

Synthesis of the acutumine spirocycle via a radical-polar crossover reaction.

Fang Li1, Steven L Castle.   

Abstract

A new radical-polar crossover reaction was developed that consists of intramolecular conjugate addition of an aryl radical followed by enolate formation and hydroxylation. A C-C bond, a C-O bond, and two congested stereocenters are created in the process. The product is obtained as a single isomer. The method was used to synthesize the spirocyclic subunit of the alkaloid acutumine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17760457     DOI: 10.1021/ol701757f

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  5 in total

1.  Stereodivergent synthesis of enantioenriched 4-hydroxy-2-cyclopentenones.

Authors:  Gurpreet Singh; Angelica Meyer; Jeffrey Aubé
Journal:  J Org Chem       Date:  2013-12-20       Impact factor: 4.354

2.  Enantioselective total synthesis of (-)-acutumine.

Authors:  Fang Li; Samuel S Tartakoff; Steven L Castle
Journal:  J Org Chem       Date:  2009-12-04       Impact factor: 4.354

Review 3.  Synthetic Strategies toward Natural Products Containing Contiguous Stereogenic Quaternary Carbon Atoms.

Authors:  Martin Büschleb; Stéphane Dorich; Stephen Hanessian; Daniel Tao; Kyle B Schenthal; Larry E Overman
Journal:  Angew Chem Int Ed Engl       Date:  2016-02-02       Impact factor: 15.336

4.  Synthetic, Mechanistic, and Biological Interrogation of Ginkgo biloba Chemical Space En Route to (-)-Bilobalide.

Authors:  Robert M Demoret; Meghan A Baker; Masaki Ohtawa; Shuming Chen; Ching Ching Lam; Sophia Khom; Marisa Roberto; Stefano Forli; Kendall N Houk; Ryan A Shenvi
Journal:  J Am Chem Soc       Date:  2020-10-16       Impact factor: 15.419

5.  A highly convergent synthesis of the C1-C31 polyol domain of amphidinol 3 featuring a TST-RCM reaction: confirmation of the revised relative stereochemistry.

Authors:  Aleksandr Grisin; P Andrew Evans
Journal:  Chem Sci       Date:  2015-08-06       Impact factor: 9.825

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.